Nuage Therapeutics appoints Dr. Stuart Hughes as CEO and Vanessa Malier as Chair
Nuage Therapeutics S.L. (“Nuage”), a biotech company focused on creating transformational precision therapies by targeting established oncogenic transcription factors, today announced the appointment of Stuart Hughes as Chief Executive Officer (CEO) and Vanessa Malier as Chair of the Board. Dr. Hughes will succeed outgoing and founding CEO, Judit Anido, who is assisting with the leadership transition.
